IntroductionThe introduction of pharmacy benefit managers (PBMs) within the United States healthcare system occurred with the aim to decrease costs and increase quality. News media and legislation have painted a picture of decreased pharmacy competition and potential negative impacts on patients and their access to affordable medications.ObjectiveThe objective of this scoping review was to evaluate the current research literature examining the impact of PBMs on the finances of community pharmacies.MethodsScientific journal articles published between 2010 and 2022 were included if they met the predefined objective.ResultsThis scoping review identified four articles that met inclusion criteria. None of the identified articles independently quantified the financial impact of PBMs on community pharmacies.ConclusionsAdditional research should be completed to specifically understand the financial impact on community pharmacies to help ensure the viability of community pharmacy as an integral access point for patients.